Implementing a national cancer clinical trials system for the 21st century: workshop summary
Saved in:
| Corporate Author: | |
|---|---|
| Format: | Electronic eBook |
| Language: | English |
| Published: |
Washington, D.C.
National Academies Press
c2011
|
| Subjects: | |
| Online Access: | FAW01 FAW02 Volltext |
| Item Description: | Includes bibliographical references (p. 91-93) Introduction -- - Panel I - NCI and the cooperative groups -- - Panel II - Payors -- - Panel III - Interactions between industry, the FDA, and the publicly funded cancer clinical trials system -- - Panel IV - Clinical trials investigators and patient advocates -- - Closing remarks "Clinical trials enable scientific discoveries to advance patient care, in addition to informing and guiding subsequent research. The National Cancer Institute's (NCI's) Clinical Trials Cooperative Group Program works to advance patient care and research. The Cooperative Group Program has been instrumental in establishing the standards for cancer patient care and clinical research methods. Despite broad participation in the program, financial strain and procedural burdens limit the ability of the Cooperative Group Program to undertake medical practice-changing clinical research. Thus, the Institute of Medicine's (IOM's) National Cancer Policy Forum and the American Society of Clinical Oncology held a workshop on March 21, 2011 to follow up on the 2010 IOM report, A National Clinical Trials System for the 21st Century: Reinvigorating the NCI Cooperative Group Program, which made recommendations to strengthen the NCI Cooperative Group Program. In keeping with the established commitment to excellence Implementing a National Cancer Clinical Trials System for the 21st Century outlines how to improve the current system by incorporating innovative science and trial design into cancer clinical trials. It also examines the impact of increasing quality in regards to speed, efficiency, design, launch, and conduct, as well as improving prioritization, and incentivized participation."--Publisher's description |
| Physical Description: | 1 Online-Ressource (xiii, 108 p.) |
| ISBN: | 0309212685 0309212693 9780309212687 9780309212694 |
Staff View
MARC
| LEADER | 00000nmm a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV043160333 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 151126s2011 |||| o||u| ||||||eng d | ||
| 020 | |a 0309212685 |9 0-309-21268-5 | ||
| 020 | |a 0309212693 |c electronic bk. |9 0-309-21269-3 | ||
| 020 | |a 9780309212687 |9 978-0-309-21268-7 | ||
| 020 | |a 9780309212694 |c electronic bk. |9 978-0-309-21269-4 | ||
| 035 | |a (OCoLC)762153479 | ||
| 035 | |a (DE-599)BVBBV043160333 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-1046 |a DE-1047 | ||
| 082 | 0 | |a 616.99406 |2 23 | |
| 110 | 2 | |a American Society of Clinical Oncology and Institute of Medicine Workshop <2011, Washington, DC> |e Verfasser |4 aut | |
| 245 | 1 | 0 | |a Implementing a national cancer clinical trials system for the 21st century |b workshop summary |c an American Society of Clinical Oncology and Institute of Medicine Workshop ; Alison Mack and Sharyl J. Nass, rapporteurs ; National Cancer Policy Forum, Board on Health Care Services, Institute of Medicine of the National Academies |
| 264 | 1 | |a Washington, D.C. |b National Academies Press |c c2011 | |
| 300 | |a 1 Online-Ressource (xiii, 108 p.) | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 500 | |a Includes bibliographical references (p. 91-93) | ||
| 500 | |a Introduction -- - Panel I - NCI and the cooperative groups -- - Panel II - Payors -- - Panel III - Interactions between industry, the FDA, and the publicly funded cancer clinical trials system -- - Panel IV - Clinical trials investigators and patient advocates -- - Closing remarks | ||
| 500 | |a "Clinical trials enable scientific discoveries to advance patient care, in addition to informing and guiding subsequent research. The National Cancer Institute's (NCI's) Clinical Trials Cooperative Group Program works to advance patient care and research. The Cooperative Group Program has been instrumental in establishing the standards for cancer patient care and clinical research methods. Despite broad participation in the program, financial strain and procedural burdens limit the ability of the Cooperative Group Program to undertake medical practice-changing clinical research. Thus, the Institute of Medicine's (IOM's) National Cancer Policy Forum and the American Society of Clinical Oncology held a workshop on March 21, 2011 to follow up on the 2010 IOM report, A National Clinical Trials System for the 21st Century: Reinvigorating the NCI Cooperative Group Program, which made recommendations to strengthen the NCI Cooperative Group Program. In keeping with the established commitment to excellence Implementing a National Cancer Clinical Trials System for the 21st Century outlines how to improve the current system by incorporating innovative science and trial design into cancer clinical trials. It also examines the impact of increasing quality in regards to speed, efficiency, design, launch, and conduct, as well as improving prioritization, and incentivized participation."--Publisher's description | ||
| 610 | 1 | 4 | |a American Society of Clinical Oncology |
| 610 | 2 | 4 | |a American Society of Clinical Oncology |
| 650 | 4 | |a Neoplasms / therapy / United States / Congresses | |
| 650 | 4 | |a Clinical Trials as Topic / standards / United States / Congresses | |
| 650 | 4 | |a Health Policy / United States / Congresses | |
| 650 | 4 | |a Patient Care / standards / United States / Congresses | |
| 650 | 7 | |a HEALTH & FITNESS / Diseases / Cancer |2 bisacsh | |
| 650 | 7 | |a MEDICAL / Oncology |2 bisacsh | |
| 650 | 4 | |a Medizin | |
| 650 | 4 | |a Politik | |
| 650 | 4 | |a Cancer |x Treatment |x Government policy |z United States | |
| 650 | 4 | |a Clinical trials |x Standards |z United States | |
| 651 | 4 | |a USA | |
| 655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |2 gnd-content | |
| 700 | 1 | |a Mack, Alison |e Sonstige |4 oth | |
| 700 | 1 | |a Nass, Sharyl J. |e Sonstige |4 oth | |
| 710 | 2 | |a National Cancer Policy Forum (U.S.) |e Sonstige |4 oth | |
| 710 | 2 | |a American Society of Clinical Oncology |e Sonstige |4 oth | |
| 710 | 2 | |a Institute of Medicine (U.S.) |b Board on Health Care Services |e Sonstige |4 oth | |
| 856 | 4 | 0 | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=400088 |x Aggregator |3 Volltext |
| 912 | |a ZDB-4-EBA | ||
| 999 | |a oai:aleph.bib-bvb.de:BVB01-028584524 | ||
| 966 | e | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=400088 |l FAW01 |p ZDB-4-EBA |q FAW_PDA_EBA |x Aggregator |3 Volltext | |
| 966 | e | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=400088 |l FAW02 |p ZDB-4-EBA |q FAW_PDA_EBA |x Aggregator |3 Volltext | |
Record in the Search Index
| _version_ | 1804175629992591360 |
|---|---|
| any_adam_object | |
| author_corporate | American Society of Clinical Oncology and Institute of Medicine Workshop <2011, Washington, DC> |
| author_corporate_role | aut |
| author_facet | American Society of Clinical Oncology and Institute of Medicine Workshop <2011, Washington, DC> |
| author_sort | American Society of Clinical Oncology and Institute of Medicine Workshop <2011, Washington, DC> |
| building | Verbundindex |
| bvnumber | BV043160333 |
| collection | ZDB-4-EBA |
| ctrlnum | (OCoLC)762153479 (DE-599)BVBBV043160333 |
| dewey-full | 616.99406 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.99406 |
| dewey-search | 616.99406 |
| dewey-sort | 3616.99406 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>04649nmm a2200613zc 4500</leader><controlfield tag="001">BV043160333</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">151126s2011 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0309212685</subfield><subfield code="9">0-309-21268-5</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0309212693</subfield><subfield code="c">electronic bk.</subfield><subfield code="9">0-309-21269-3</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780309212687</subfield><subfield code="9">978-0-309-21268-7</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780309212694</subfield><subfield code="c">electronic bk.</subfield><subfield code="9">978-0-309-21269-4</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)762153479</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV043160333</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-1046</subfield><subfield code="a">DE-1047</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.99406</subfield><subfield code="2">23</subfield></datafield><datafield tag="110" ind1="2" ind2=" "><subfield code="a">American Society of Clinical Oncology and Institute of Medicine Workshop <2011, Washington, DC></subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Implementing a national cancer clinical trials system for the 21st century</subfield><subfield code="b">workshop summary</subfield><subfield code="c">an American Society of Clinical Oncology and Institute of Medicine Workshop ; Alison Mack and Sharyl J. Nass, rapporteurs ; National Cancer Policy Forum, Board on Health Care Services, Institute of Medicine of the National Academies</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Washington, D.C.</subfield><subfield code="b">National Academies Press</subfield><subfield code="c">c2011</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (xiii, 108 p.)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references (p. 91-93)</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Introduction -- - Panel I - NCI and the cooperative groups -- - Panel II - Payors -- - Panel III - Interactions between industry, the FDA, and the publicly funded cancer clinical trials system -- - Panel IV - Clinical trials investigators and patient advocates -- - Closing remarks</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">"Clinical trials enable scientific discoveries to advance patient care, in addition to informing and guiding subsequent research. The National Cancer Institute's (NCI's) Clinical Trials Cooperative Group Program works to advance patient care and research. The Cooperative Group Program has been instrumental in establishing the standards for cancer patient care and clinical research methods. Despite broad participation in the program, financial strain and procedural burdens limit the ability of the Cooperative Group Program to undertake medical practice-changing clinical research. Thus, the Institute of Medicine's (IOM's) National Cancer Policy Forum and the American Society of Clinical Oncology held a workshop on March 21, 2011 to follow up on the 2010 IOM report, A National Clinical Trials System for the 21st Century: Reinvigorating the NCI Cooperative Group Program, which made recommendations to strengthen the NCI Cooperative Group Program. In keeping with the established commitment to excellence Implementing a National Cancer Clinical Trials System for the 21st Century outlines how to improve the current system by incorporating innovative science and trial design into cancer clinical trials. It also examines the impact of increasing quality in regards to speed, efficiency, design, launch, and conduct, as well as improving prioritization, and incentivized participation."--Publisher's description</subfield></datafield><datafield tag="610" ind1="1" ind2="4"><subfield code="a">American Society of Clinical Oncology</subfield></datafield><datafield tag="610" ind1="2" ind2="4"><subfield code="a">American Society of Clinical Oncology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Neoplasms / therapy / United States / Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Clinical Trials as Topic / standards / United States / Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Health Policy / United States / Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Patient Care / standards / United States / Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">HEALTH & FITNESS / Diseases / Cancer</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Oncology</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medizin</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Politik</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cancer</subfield><subfield code="x">Treatment</subfield><subfield code="x">Government policy</subfield><subfield code="z">United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Clinical trials</subfield><subfield code="x">Standards</subfield><subfield code="z">United States</subfield></datafield><datafield tag="651" ind1=" " ind2="4"><subfield code="a">USA</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mack, Alison</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Nass, Sharyl J.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">National Cancer Policy Forum (U.S.)</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">American Society of Clinical Oncology</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">Institute of Medicine (U.S.)</subfield><subfield code="b">Board on Health Care Services</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=400088</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-EBA</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-028584524</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=400088</subfield><subfield code="l">FAW01</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FAW_PDA_EBA</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=400088</subfield><subfield code="l">FAW02</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FAW_PDA_EBA</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| genre | (DE-588)1071861417 Konferenzschrift gnd-content |
| genre_facet | Konferenzschrift |
| geographic | USA |
| geographic_facet | USA |
| id | DE-604.BV043160333 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T07:19:20Z |
| institution | BVB |
| isbn | 0309212685 0309212693 9780309212687 9780309212694 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-028584524 |
| oclc_num | 762153479 |
| open_access_boolean | |
| owner | DE-1046 DE-1047 |
| owner_facet | DE-1046 DE-1047 |
| physical | 1 Online-Ressource (xiii, 108 p.) |
| psigel | ZDB-4-EBA ZDB-4-EBA FAW_PDA_EBA |
| publishDate | 2011 |
| publishDateSearch | 2011 |
| publishDateSort | 2011 |
| publisher | National Academies Press |
| record_format | marc |
| spelling | American Society of Clinical Oncology and Institute of Medicine Workshop <2011, Washington, DC> Verfasser aut Implementing a national cancer clinical trials system for the 21st century workshop summary an American Society of Clinical Oncology and Institute of Medicine Workshop ; Alison Mack and Sharyl J. Nass, rapporteurs ; National Cancer Policy Forum, Board on Health Care Services, Institute of Medicine of the National Academies Washington, D.C. National Academies Press c2011 1 Online-Ressource (xiii, 108 p.) txt rdacontent c rdamedia cr rdacarrier Includes bibliographical references (p. 91-93) Introduction -- - Panel I - NCI and the cooperative groups -- - Panel II - Payors -- - Panel III - Interactions between industry, the FDA, and the publicly funded cancer clinical trials system -- - Panel IV - Clinical trials investigators and patient advocates -- - Closing remarks "Clinical trials enable scientific discoveries to advance patient care, in addition to informing and guiding subsequent research. The National Cancer Institute's (NCI's) Clinical Trials Cooperative Group Program works to advance patient care and research. The Cooperative Group Program has been instrumental in establishing the standards for cancer patient care and clinical research methods. Despite broad participation in the program, financial strain and procedural burdens limit the ability of the Cooperative Group Program to undertake medical practice-changing clinical research. Thus, the Institute of Medicine's (IOM's) National Cancer Policy Forum and the American Society of Clinical Oncology held a workshop on March 21, 2011 to follow up on the 2010 IOM report, A National Clinical Trials System for the 21st Century: Reinvigorating the NCI Cooperative Group Program, which made recommendations to strengthen the NCI Cooperative Group Program. In keeping with the established commitment to excellence Implementing a National Cancer Clinical Trials System for the 21st Century outlines how to improve the current system by incorporating innovative science and trial design into cancer clinical trials. It also examines the impact of increasing quality in regards to speed, efficiency, design, launch, and conduct, as well as improving prioritization, and incentivized participation."--Publisher's description American Society of Clinical Oncology Neoplasms / therapy / United States / Congresses Clinical Trials as Topic / standards / United States / Congresses Health Policy / United States / Congresses Patient Care / standards / United States / Congresses HEALTH & FITNESS / Diseases / Cancer bisacsh MEDICAL / Oncology bisacsh Medizin Politik Cancer Treatment Government policy United States Clinical trials Standards United States USA (DE-588)1071861417 Konferenzschrift gnd-content Mack, Alison Sonstige oth Nass, Sharyl J. Sonstige oth National Cancer Policy Forum (U.S.) Sonstige oth American Society of Clinical Oncology Sonstige oth Institute of Medicine (U.S.) Board on Health Care Services Sonstige oth http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=400088 Aggregator Volltext |
| spellingShingle | Implementing a national cancer clinical trials system for the 21st century workshop summary American Society of Clinical Oncology Neoplasms / therapy / United States / Congresses Clinical Trials as Topic / standards / United States / Congresses Health Policy / United States / Congresses Patient Care / standards / United States / Congresses HEALTH & FITNESS / Diseases / Cancer bisacsh MEDICAL / Oncology bisacsh Medizin Politik Cancer Treatment Government policy United States Clinical trials Standards United States |
| subject_GND | (DE-588)1071861417 |
| title | Implementing a national cancer clinical trials system for the 21st century workshop summary |
| title_auth | Implementing a national cancer clinical trials system for the 21st century workshop summary |
| title_exact_search | Implementing a national cancer clinical trials system for the 21st century workshop summary |
| title_full | Implementing a national cancer clinical trials system for the 21st century workshop summary an American Society of Clinical Oncology and Institute of Medicine Workshop ; Alison Mack and Sharyl J. Nass, rapporteurs ; National Cancer Policy Forum, Board on Health Care Services, Institute of Medicine of the National Academies |
| title_fullStr | Implementing a national cancer clinical trials system for the 21st century workshop summary an American Society of Clinical Oncology and Institute of Medicine Workshop ; Alison Mack and Sharyl J. Nass, rapporteurs ; National Cancer Policy Forum, Board on Health Care Services, Institute of Medicine of the National Academies |
| title_full_unstemmed | Implementing a national cancer clinical trials system for the 21st century workshop summary an American Society of Clinical Oncology and Institute of Medicine Workshop ; Alison Mack and Sharyl J. Nass, rapporteurs ; National Cancer Policy Forum, Board on Health Care Services, Institute of Medicine of the National Academies |
| title_short | Implementing a national cancer clinical trials system for the 21st century |
| title_sort | implementing a national cancer clinical trials system for the 21st century workshop summary |
| title_sub | workshop summary |
| topic | American Society of Clinical Oncology Neoplasms / therapy / United States / Congresses Clinical Trials as Topic / standards / United States / Congresses Health Policy / United States / Congresses Patient Care / standards / United States / Congresses HEALTH & FITNESS / Diseases / Cancer bisacsh MEDICAL / Oncology bisacsh Medizin Politik Cancer Treatment Government policy United States Clinical trials Standards United States |
| topic_facet | American Society of Clinical Oncology Neoplasms / therapy / United States / Congresses Clinical Trials as Topic / standards / United States / Congresses Health Policy / United States / Congresses Patient Care / standards / United States / Congresses HEALTH & FITNESS / Diseases / Cancer MEDICAL / Oncology Medizin Politik Cancer Treatment Government policy United States Clinical trials Standards United States USA Konferenzschrift |
| url | http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=400088 |
| work_keys_str_mv | AT americansocietyofclinicaloncologyandinstituteofmedicineworkshop2011washingtondc implementinganationalcancerclinicaltrialssystemforthe21stcenturyworkshopsummary AT mackalison implementinganationalcancerclinicaltrialssystemforthe21stcenturyworkshopsummary AT nasssharylj implementinganationalcancerclinicaltrialssystemforthe21stcenturyworkshopsummary AT nationalcancerpolicyforumus implementinganationalcancerclinicaltrialssystemforthe21stcenturyworkshopsummary AT americansocietyofclinicaloncology implementinganationalcancerclinicaltrialssystemforthe21stcenturyworkshopsummary AT instituteofmedicineusboardonhealthcareservices implementinganationalcancerclinicaltrialssystemforthe21stcenturyworkshopsummary |